Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Pavel A. Zatolokin"'
Autor:
Daria A. Skuratovskaia, Maria A. Vulf, Elena V. Kirienkova, Natalia I. Myronyuk, Pavel A. Zatolokin, Larisa S. Litvinova
Publikováno v:
Сахарный диабет, Vol 22, Iss 3, Pp 217-224 (2019)
BACKGROUND: Glucagon-like peptide-1 (GLP-1) stimulates the proliferation of β-cells, enhances their resistance to apoptosis and increases glucose-dependent insulin secretion. AIMS: Study of the relationship of Leu260Phe polymorphism (rs1042044) of t
Externí odkaz:
https://doaj.org/article/f520af947a3b4dd080631b786275ae63
Autor:
Daria S. Skuratovskaia, Maria A. Vasilenko, Nikolai S. Fattakhov, Elena V. Kirienkova, Natalia I. Mironyuk, Pavel A. Zatolokin, Larisa S. Litvinova
Publikováno v:
Сахарный диабет, Vol 19, Iss 6, Pp 457-463 (2016)
Aim. To investigate the association of the GIPR gene polymorphisms rs2302382 and rs8111428 with increased risk of type 2 diabetes mellitus and abdominal obesity.Materials and methods. The study involved 163 patients with abdominal obesity (BMI, 39.5
Externí odkaz:
https://doaj.org/article/31fef091779a45a9a984177e798ad7a5
Autor:
Larisa Sergeevna Litvinova, Maria Alexandrovna Vasilenko, Pavel Anatol'evich Zatolokin, Natalya Nikolaevna Aksenova, Nikolay Sergeevich Fattakhov, Igor Zinov'evich Vaysbeyn, Natalya Ivanovna Mironyuk, Elena Vital'evna Kirienkova
Publikováno v:
Сахарный диабет, Vol 17, Iss 3, Pp 51-59 (2014)
Bariatric surgery serves as a model for the assessment of the relationship between body mass index (BMI) reduction and changes in adipokine production and for exploring the endocrine function of the pancreas in patients who do not have the proximal p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::305e86feaaa8d7c230c84776427727df
https://www.dia-endojournals.ru/jour/article/view/6312
https://www.dia-endojournals.ru/jour/article/view/6312
Autor:
Elena Vital'evna Kirienkova, Mariia Aleksandrovna Vasilenko, Pavel Anatol'evich Zatolokin, Nataliya Ivanovna Mironyuk, Dar'ya Aleksandrovna Skuratovskaia, Larisa Sergeevna Litvinova
Publikováno v:
Сахарный диабет, Vol 18, Iss 4, Pp 22-27 (2015)
Background. The main aims of the conservative treatment of metabolic obesity (MО) are weight loss and the prevention of type 2 diabetes. Incretin-based drugs are considered to be effective and safe and stimulate insulin secretion via the β-cells of
Externí odkaz:
https://doaj.org/article/d3be2bef7b97498a863648c5dc8d11c5